Wolverine Blend
BPC-157 + TB-500 healing blend
Wolverine Blend (BPC-157 + TB-500 healing blend) is a blends & other research compound. The soft-tissue repair blend — BPC-157 and TB-500 in one draw. BPC-157 drives angiogenesis, tendon/ligament fibroblast migration and gut/vascular repair; TB-500 (the active fragment of thymosin beta-4) sequesters actin to accelerate cell migration and systemic recovery. Together they hit both the local and systemic arms of tissue healing.
Wolverine Blend quick facts
| Reported research dose | 1-3mg GHK-Cu & 200-600mcg BPC,TB,KPV |
| Route | Subq |
| Frequency | 1x Daily · 5 On 2 Off or Daily |
| Half-life | Mixed (BPC short · TB days) |
| Forms | Injectable |
| Evidence level | Anecdotal (blend) |
The 'Wolverine' healing stack — one shot instead of two draws. Mixed evenly, usually 5/5mg or 10/10mg per vial.
How Wolverine Blend works
The soft-tissue repair blend — BPC-157 and TB-500 in one draw. BPC-157 drives angiogenesis, tendon/ligament fibroblast migration and gut/vascular repair; TB-500 (the active fragment of thymosin beta-4) sequesters actin to accelerate cell migration and systemic recovery. Together they hit both the local and systemic arms of tissue healing.
Proposed benefits
A combination formula — proposed benefits reflect the sum of its individual components.
✅ Clinically validated
- No trial of the blend. It combines BPC-157 and TB-500 — the two most-used repair peptides — so its evidence is theirs. See each component's clinical tier, both of which are honest about the absence of completed human trials.
📊 Correlative data
- The most common repair pairing in the research space, sold pre-combined for convenience. Reported experience is what you would expect from running both separately.
🧪 Theoretical / extrapolated
- Two complementary repair mechanisms: BPC-157 drives angiogenesis at the injury site, TB-500 drives the migration of repair cells into it. Blood supply and cell delivery are different halves of the same job, which is the mechanistic case for pairing them and the reason this blend exists rather than a double dose of either.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
Wolverine Blend — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- A BPC-157 and TB-500 combination under a brand name. No new mechanism — if you already run either peptide, this is the same thing repackaged.
- *the BPC-157 / TB-500 arms:* Repair peptides work by promoting angiogenesis — new blood vessel growth — plus fibroblast migration and growth-factor signalling. That is what makes them useful, and it is the entire basis of the one theoretical concern worth naming: angiogenesis is also what a tumour needs to grow beyond a few millimetres.
- *the BPC-157 / TB-500 arms:* There is no evidence these compounds cause or accelerate cancer. There is a mechanistic reason not to run a pro-angiogenic agent systemically with an active or recently treated malignancy, and that reasoning stands without a trial.
- *the BPC-157 / TB-500 arms:* The second predicted issue is more mundane and more likely: they can mask a signal. Something that reduces pain and inflammation around an injury lets you load a tissue that has not finished healing.
- The risk that belongs to the blend rather than any component: double-dosing. If you already run any of the peptides above separately, adding this blend means two doses of it — and almost nobody counts a blend's arms against what is already in their protocol. Read the composition against your current stack before the first injection.
What has actually been reported
- *the BPC-157 / TB-500 arms:* Very well tolerated in reported use. Injection-site reactions and transient light-headedness are the common complaints.
- *the BPC-157 / TB-500 arms:* Human data is thin — most of the literature is rodent — so 'well tolerated' here means 'no signal has emerged from a lot of informal use', which is weaker than a clean trial and stronger than nothing.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- *the BPC-157 / TB-500 arms:* Stop when the thing you were treating has resolved. There is no mechanism here that demands a clock, and equally no reason to keep running a pro-angiogenic signal once the job is done.
- *the BPC-157 / TB-500 arms:* Do not let reduced pain set your training load. The tissue heals on its own timeline whether or not you can feel it. Reloading early on the strength of feeling better is the most common way people turn a good result into a re-injury.
- *the BPC-157 / TB-500 arms:* Get the diagnosis before the peptide. These accelerate healing of things that heal. A tear that needs surgical repair does not become a tear that does not, and the delay costs you.
- *the BPC-157 / TB-500 arms:* One injury, one compound, long enough to judge it. Otherwise you learn nothing transferable for next time.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- *the BPC-157 / TB-500 arms:* Nothing routine tracks these directly. The endpoint is the injury, which means your own honest assessment of function is the measurement.
Don't run this if
- *the BPC-157 / TB-500 arms:* Active or recently treated malignancy — the angiogenesis reasoning.
- *the BPC-157 / TB-500 arms:* Any undiagnosed lump or lesion. Find out what it is first.
The honest unknown
- *the BPC-157 / TB-500 arms:* Long-term systemic exposure in humans has never been characterised. The use case is naturally self-limiting — you stop when the injury resolves — which is why this matters less here than it would elsewhere.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Where to get Wolverine Blend
Buy Wolverine Blend at Disguised Alpha →Wolverine Blend — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What Wolverine Blend moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- hs-CRP (High-Sensitivity C-Reactive Protein) — ↓ expected to fall
From the BPC-157 / TB-500 arm. If a repair peptide is doing anything systemic, inflammation is where it would plausibly show.
What to do: Worth a baseline if you are running one for a chronic issue rather than an acute injury. - Comprehensive Metabolic Panel (CMP) — ◆ worth watching
From the BPC-157 / TB-500 arm. Standard baseline. Nothing in this class predicts a specific abnormality — which is itself worth saying rather than inventing one.
What to do: Annual is fine unless something changes.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for Wolverine Blend — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →A BPC-157 and TB-500 combination under a brand name. Nothing here is a new mechanism — if you are already running either peptide, this is the same thing at a different price.
- How to work up to it, and when not to
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- Needle gauge and injection site
- How the forms differ in dose
- Coach Cam's personal notes
Get the complete breakdown for Wolverine Blend — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside Wolverine Blend
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| Comprehensive Metabolic Panel (CMP) | Liver, kidney, electrolytes and glucose in one |
| Complete Blood Count (CBC) with Differential | Broad screen for anything unexpected |
| hs-CRP (High-Sensitivity C-Reactive Protein) | Inflammation baseline |
The The Basics — Start Here panel covers these in one order — 4 markers, $32.40 with the discount applied.
Check results you already have → · All 102 markers A–Z
Wolverine Blend — frequently asked questions
What is Wolverine Blend?
Wolverine Blend (BPC-157 + TB-500 healing blend) is a blends & other research compound. The soft-tissue repair blend — BPC-157 and TB-500 in one draw. BPC-157 drives angiogenesis, tendon/ligament fibroblast migration and gut/vascular repair; TB-500 (the active fragment of thymosin beta-4) sequesters actin to accelerate cell migration and systemic recovery. Together they hit both the local and systemic arms of tissue healing.
Is the full Wolverine Blend protocol on this page?
The reported research dose is on this page, along with how Wolverine Blend works and the evidence behind it. The protocol — how to work up to it, frequency, cycle length, time off, what not to stack it with and Coach Cam's notes — is inside the Academy.
What is the half-life of Wolverine Blend?
Wolverine Blend has an approximate half-life of Mixed (BPC short · TB days), which is part of what determines how often it's dosed.
What's the evidence behind Wolverine Blend?
Current evidence level: Anecdotal (blend). Wolverine Blend is offered for research purposes only and is not an approved medicine.
Want Coach Cam's exact Wolverine Blend protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What Wolverine Blend is used for
Wolverine Blend appears under 1 goal in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.